Literature DB >> 23993671

Divergent and convergent synthesis of polymannosylated dibranched antigenic peptide of the immunodominant epitope MBP(83-99).

Irene Friligou1, Fabio Rizzolo, Francesca Nuti, Theodore Tselios, Maria Evangelidou, Mary Emmanouil, Maria Karamita, John Matsoukas, Mario Chelli, Paolo Rovero, Anna Maria Papini.   

Abstract

Multiple antigenic peptide (MAP) systems are dendrimeric structures bearing multiple copies of identical or different peptide epitopes, and they have been demonstrated to show enhanced immunogenicity. Herein, we report the direct (divergent) and indirect (convergent) synthesis, using contemporary synthetic approaches, of a di-branched antigenic peptide (di-BAP) containing the immunodominant epitope MBP(83-99), which is implicated in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). The direct synthesis (di-BAP 1) was performed using microwave irradiation. The indirect synthesis (di-BAP 2) was carried out performing an efficient chemoselective coupling reaction through the formation of a thioether bond. Both di-BAPs were conjugated to polysaccharide mannan since mannosylation is a promising technique to achieve modulation in immune response. The conjugation was achieved through free amino groups of both di-BAPs via the formation of Schiff bases. The mannan-conjugated di-BAPs were further evaluated in vivo in a prophylactic vaccination protocol, prior to EAE induction in Lewis rats.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Convergent synthesis; Di-branched antigenic peptide; Divergent synthesis; Experimental autoimmune encephalomyelitis; Mannosylation; Microwave-assisted synthesis

Mesh:

Substances:

Year:  2013        PMID: 23993671     DOI: 10.1016/j.bmc.2013.08.008

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Discovery of a stable tripeptide targeting the N-domain of CRF1 receptor.

Authors:  George Liapakis; Vlasios Karageorgos; Ioannis Andreadelis; George G Holz; Eirini Dermitzaki; Golfo G Kordopati; Evgenios Κ Stylos; Katerina Spyridaki; Smaragda Poulaki; Dimitris Ntountaniotis; Stelios Sakellaris; Marianna Vanioti; Androniki Kostagianni; Konstantinos D Marousis; Georgios Leonis; George Kokotos; Maria Venihaki; Georgios A Spyroulias; Theodoros Tselios; Andrew Margioris; Andreas G Tzakos; Thomas Mavromoustakos
Journal:  Amino Acids       Date:  2020-09-29       Impact factor: 3.520

2.  Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple Sclerosis.

Authors:  Stephanie Day; Theodore Tselios; Maria-Eleni Androutsou; Anthi Tapeinou; Irene Frilligou; Lily Stojanovska; John Matsoukas; Vasso Apostolopoulos
Journal:  Front Immunol       Date:  2015-04-07       Impact factor: 7.561

3.  Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis.

Authors:  Maria-Eleni Androutsou; Agathi Nteli; Areti Gkika; Maria Avloniti; Anastasia Dagkonaki; Lesley Probert; Theodore Tselios; Simona Golič Grdadolnik
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

4.  A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87-99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis.

Authors:  Mary Emmanouil; Vivian Tseveleki; Iro Triantafyllakou; Agathi Nteli; Theodore Tselios; Lesley Probert
Journal:  Molecules       Date:  2018-01-31       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.